Sensex, Nifty fall up to 0.7% on U.S. tariff fears; realty, pharma lead losses

/1 min read

ADVERTISEMENT

At the time of reporting, the Nifty was trading 162 points lower at 24,805, and the Sensex was down 551 points at 81,084.
THIS STORY FEATURES
Tata Steel Ltd Fortune 500 India 2024
Shriram Finance Ltd Fortune 500 India 2024
Sun Pharmaceuticals Industries Ltd Fortune 500 India 2024
Sensex, Nifty fall up to 0.7% on U.S. tariff fears; realty, pharma lead losses
Nifty 50 and Sensex both fell up to 0.7% each in the first half of today’s trading session Credits: Narendra Bisht
In this story

Indian benchmark indices, Nifty 50 and Sensex, both fell up to 0.7% each in the first half of today’s trading session, after the United States issued a draft notice to impose additional tariffs of 25% on Indian goods from August 27, Wednesday.

At the time of reporting, Nifty was trading 162 points lower at 24,805, and Sensex was down 551 points at 81,084Broader markets also showcased weak trends, while among sectoral indices, all except Nifty FMCG were trading in the red.

The major losers were Nifty Realty and Nifty Healthcare, slipping 1.7% and 1.33%, respectively. Even Nifty Pharma dipped by 1.28%. Nifty Auto fell 0.6% in the early hours but gained positive momentum and recovered by 30 bps.

fortune magazine cover
Fortune India Latest Edition is Out Now!
The Year Of EV Launches

September 2025

2025 is shaping up to be the year of electric car sales. In a first, India’s electric vehicles (EV) industry crossed the sales milestone of 100,000 units in FY25, fuelled by a slew of launches by major players, including Tata Motors, M&M, Ashok Leyland, JSW MG Motor, Hyundai, BMW, and Mercedes-Benz. The issue also looks at the challenges ahead for Tata Sons chairman N. Chandrasekaran in his third term, and India’s possible responses to U.S. president Donald Trump’s 50% tariff on Indian goods. Read these compelling stories in the latest issue of Fortune India.

Read Now

The India VIX, the market volatility yardstick, rose 3.86 points to 12.21, reflecting investors’ heightened risk perception. Among Nifty’s top 50, the major laggards were Shriram Finance, Sun Pharmaceutical Industries, Tata Steel, Dr. Reddy's Laboratories, and Coal India, declining up to 2.5%.

In Nifty Realty, Godrej Properties, Lodha, and DLF led losses by nearly 2% each. Nifty Pharma was trading at 22,082.55, lower by 280 points, with loss-making companies Zydus Lifesciences, Sun Pharmaceuticals, and Lupin dragging the sectoral index down by nearly 3%.

Nestle, Eicher Motors, and Hindustan Unilever topped the Nifty 50 gainers’ list, rising 1.64%, 1.46%, and 1.44%, respectively.

Fortune India is now on WhatsApp! Get the latest updates from the world of business and economy delivered straight to your phone. Subscribe now.